Patents
Patents for C07B 59 - Introduction of isotopes of elements into organic compounds (2,678)
04/2000
04/26/2000EP0995761A2 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
04/25/2000US6054114 Diagnosing the degree of progression of alzheimer's disease in a mammal, monitoring the response to a therapy in a mammal having alzheimer's disease, identifying an agent useful for treating alzheimer's disease
04/12/2000EP0991660A1 Deuterated cyclosporine analogs and their use as immunomodulating agents
04/06/2000WO2000018403A1 Radiolabeled neurokinin-1 receptor antagonists
04/06/2000CA2343106A1 Radiolabeled neurokinin-1 receptor antagonists
04/04/2000CA2105402C Radiolabelled compound formulations
03/2000
03/29/2000EP0988263A1 Process for the production of radioiodinated neuroreceptor agents
03/01/2000EP0759913B1 Aromatic amine substituted bridged nitrogen and sulfur donor atom ligands for imaging
02/2000
02/29/2000US6030843 Site reactivity probes for the environment
02/24/2000WO1999063547A3 Apparatus for the preparation of radioactive solutions
02/15/2000US6024937 Targets of proteins, biotin and hydrolyzable group of imide, ester or carbamate
02/15/2000CA1340899C Procede de preparation de complexes nitruro 99m tc, 186 re ou 188 re utilisables comme produits radiopharmaceutiques
02/09/2000EP0977815A1 ALKYL, ALKENYL AND ALKYNYL CHRYSAMINE G DERIVATIVES FOR THE ANTEMORTEM DIAGNOSIS OF ALZHEIMER'S DISEASE AND $i(IN VIVO) IMAGING AND PREVENTION OF AMYLOID DEPOSITION
02/08/2000US6022523 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
02/02/2000EP0975669A1 Calcitonin receptor-binding peptides
02/02/2000EP0975595A1 Analogs of cocaine
02/01/2000US6019957 Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
01/2000
01/26/2000EP0974572A1 Novel process for producing alcohols
01/25/2000US6017509 Cyclic hexapeptides not comprised of a disulfide bond covalently linked to a radiolabel e.g. technetium; scintigraphic imaging agents; radiodiagnosis and -therapy; antitumor,-carcinogenic and -diabetic agents; stability
01/18/2000US6015904 Stable reagents for the preparation of radio pharmaceuticals
01/18/2000US6015543 Diagnosis of tumors
01/05/2000EP0570493B1 TECHNETIUM-99m LABELED POLYPEPTIDES FOR IMAGING
01/04/2000US6010680 Thiolation of proteins for radionuclide-based radioimmunodetection and radioimmunotherapy
01/04/2000US6010679 Transition metal radionucleolide; contrast agents for diagnosing cardiovascular disorders, cancer
12/1999
12/28/1999US6008421 Production of 11 C-methyl iodide
12/28/1999US6008398 Non-nucleotide phosphorus ester oligomers
12/28/1999US6007792 Chelate compounds labeled with technetium-99m, rhenium-186, or rhenium-188; tumor imaging
12/21/1999US6004531 Metal chelating compounds having an SNNN donor set
12/16/1999WO1999064389A1 Inhibitors of the anandamide transporter as analgesic agents
12/16/1999CA2337822A1 Inhibitors of the anandamide transporter as analgesic agents
12/14/1999US6001979 Cores for technetium radiopharmaceuticals
12/14/1999US6001330 Diamine dopamine or serotonin ligand of given formula; labeled with a radionuclide and administered for imaging dopamine neurons in a mammal; treating cocaine abuse
12/09/1999WO1999063547A2 Apparatus for the preparation of radioactive solutions
12/09/1999CA2333937A1 Apparatus for the preparation of radioactive solutions
12/08/1999EP0594837B2 Radiolabelled compound formulations
12/07/1999US5997843 Radiometal complexes that localise in hypoxic tissue
12/01/1999CN1046857C Tris (isonitrile) copper sulfates and its preparing process
11/1999
11/30/1999US5993777 Benzamide compounds for cancer imaging and therapy
11/30/1999US5993775 Peptides which bind technetium or rhenium and which can be targeted to specific sites within a mammalian body.
11/30/1999US5993774 Metal-oxime chelates for use as radiopharmaceutical agents
11/25/1999WO1999060018A1 Labelled glutamine and lysine analogues
11/25/1999WO1999059642A1 Labeled drugs and nitroxyl compounds to be used therein
11/25/1999CA2332277A1 Labelled glutamine and lysine analogues
11/16/1999US5985334 Contacting test compound to receptor from rat brain tissue that binds 6-acetyl-4-benzamido-3-hydroxy-2,2-dimethylbenzopyran derivatives
11/16/1999US5985241 Diagnostic and radiodiagnostic agents, formed by reacting technetium-99m with a somatostatin receptor-binding peptide
11/11/1999WO1999056791A1 S3n radionuclide complexes
11/09/1999US5981477 Peptide-metal chelate conjugates
11/02/1999US5976497 3-(4-(2-pyridinyl))piperazinylmethyl)pyrrolo(2.3-b)pyridine and derivatives
10/1999
10/26/1999US5972308 Reacting technetium-99 with a cyclic oligopeptide having amino acid units containing a mercaptan group attached to the ring through a homocysteine unit.
10/19/1999US5968476 Technetium-99m labeled peptides for thrombus imaging
10/14/1999WO1999051560A1 Synthetic endogenous cannabinoids analogues and uses thereof
10/14/1999CA2326766A1 Synthetic endogenous cannabinoids analogues and uses thereof
10/13/1999EP0949632A2 Method for preparing (F-18)-fluoride ion.
10/13/1999EP0949232A1 Difluorophenyl derivatives, liquid-crystal compounds, and liquid-crystal composition
10/12/1999US5965108 Cyclic peptide-metal complex specifically binds to surface somatostatin receptor-expressing cells; radiology; scintigraphy; antitumor,-carcinogenic and metastatic agents; stability
10/06/1999EP0946204A1 Process for the preparation of radiopharmaceuticals
09/1999
09/29/1999CN1045290C Method for preparation of chelans possesing ortho ligating functionality and complexes
09/22/1999EP0663900B1 Metal-oxime chelates for use as radiopharmaceutical agents
09/10/1999WO1999044970A1 Method for producing [15o] butanol and device for implementing said method
09/09/1999DE19809960A1 Verfahren zur Herstellung von [·1··5·O]Butanol und Vorrichtung zur Durchführung des Verfahrens A process for the preparation of [5 · 1 · · · O] butanol and apparatus for carrying out the method
09/01/1999EP0650475B1 4-amino-n-(4-methyl-4-piperidinyl)-2-methoxybenzamides, their preparation and their use as 5-ht2 antagonists
08/1999
08/31/1999US5945564 2,2-dideutero-5-aminolevulinic acid
08/04/1999EP0644775B1 Cocaine Receptor Binding Ligands
08/03/1999US5932707 Thioether-containing metal chelating compounds
07/1999
07/21/1999EP0929533A1 4,4-disubstituted-1,4-dihydro-2h-3,1-benzoxazin-2-ones useful as hiv reverse transcriptase inhibitors and intermediates and processes for making the same
07/20/1999US5925332 Radioimaging and radiochemotherapy phenolic thioether amines and acyl derivatives thereof for use in diagnosing and treating pigmentation disorders
07/13/1999US5922301 Radiolabelled amino acid formulations stored in an unfrozen state
07/06/1999US5919965 Library mixtures; target binding
07/06/1999US5919797 Halogenated naphthyl methoxy piperidines for mapping serotonin transporter sites
06/1999
06/30/1999EP0563328B1 Tc(III)-99m MYOCARDIAL IMAGING AGENTS AND METHOD OF USE
06/23/1999CN1220656A Novel trienoic retinoid compounds and method
06/22/1999US5914096 Arsenic-72 labeled compounds for tissue specific medical imaging
06/15/1999US5911970 Antitumor agents and anticarcinogenic agents
06/02/1999CN1218461A Alkylaminobenzothiazole and -benzoxazole derivatives
05/1999
05/20/1999WO1999024080A1 Para-hydrogen labelled agents and their use in magnetic resonance imaging
05/19/1999EP0713513A4 Tris(isonitrile)copper(i) sulfates for preparing radionuclide complexes
05/06/1999WO1999013920A3 Method for treating proliferative diseases by therapy
05/06/1999EP0912566A1 Pyrrolo 2,3-b]pyridine derivatives, useful as radiolabelled d4 receptor ligands
05/06/1999EP0912533A1 Alkylaminobenzothiazole and -benzoxazole derivatives
04/1999
04/21/1999EP0692976B1 Chelating agents of the type xn 1?s 1?o 1? for radioactive isotopes, metal complexes thereof, and their use in diagnosis and therapy
04/15/1999WO1999018120A1 Deuterated cyclosporine analogs and their use as immunomodulating agents
04/15/1999WO1999018053A1 Preparation of radiolabelled haloaromatics via polymer-bound intermediates
04/08/1999WO1999016757A1 Contrasting agent for infarct and necrosis imaging
04/08/1999CA2304458A1 Contrasting agent for infarct and necrosis imaging
04/01/1999WO1998055153A9 Non-steroidal radiolabeled agonist/antagonist compounds and their use in prostate cancer imaging
03/1999
03/31/1999EP0905135A2 Cocaine receptor binding ligands
03/30/1999US5888474 Technetium-99m labeled peptides for GPIIb/IIIa ligands useful for thrombus imaging
03/25/1999WO1999013920A2 Method for treating proliferative diseases by therapy
03/25/1999DE19742880A1 Treatment of proliferative or atherosclerotic diseases
03/25/1999CA2301887A1 Method for treating proliferative diseases by therapy
03/23/1999US5886190 Reacting glycerol-1,3-ditosylate-2-o-acetylate with 2-nitroimidazole to form chemical intermediate 1-(2'-nitro-1'-imidazolyl)-2-o-acetyl-3-o-tosylpropanol in presence of dimethylformamide and cesium carbonate
03/18/1999WO1999012893A1 Diagnostic and therapeutic alkylenediamine compounds and process
03/11/1999WO1999011590A1 Fluorination of proteins and peptides for f-18 positron emission tomography
03/11/1999WO1999011589A1 13c, 15n, 2h labeled proteins for nmr structure determinations and their preparation
03/09/1999US5879658 Technetium-99m labeled peptides for thrombus imaging
03/09/1999US5879657 Radiolabeled platelet GPIIb/IIIa receptor antagonists as imaging agents for the diagnosis of thromboembolic disorders
02/1999
02/24/1999EP0897922A2 Cocaine receptor binding ligands
02/03/1999EP0724601A4 S 3n chelating compounds for the radiolabeling of ligands, anti-ligands or other proteins
02/02/1999US5866097 Technetium-99m labeled peptides for imaging
01/1999
01/19/1999CA2165294C An iodinated neuroprobe for mapping monoamine reuptake sites
1 ... 9 10 11 12 13 14 15 16 17 18 19 20 21 22 23 24 25 26 27